| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
Staar Surgical Co
13D/A
STAA · 852312305
|
6.5% |
1/16/2026
Event 1/14/2026
|
||||
| Yunqi Path Capital Master Fund | 5.2% | |||||
| Yunqi Capital Limited | 6.5% | |||||
| Yunqi Capital Cayman Limited | 6.5% | |||||
| Christopher Min Fang Wang | 6.5% | |||||
| Yunqi China Special Investment A | 1.4% | |||||
| HS Group Master Fund II Ltd | 1.4% | |||||
| HS Group (Hong Kong) Limited | 1.4% | |||||
| HS Group Ltd | 1.4% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.